Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
160M
-
Shares change
-
-595K
-
Total reported value, excl. options
-
$7.84B
-
Value change
-
-$42.3M
-
Put/Call ratio
-
0.71
-
Number of buys
-
120
-
Number of sells
-
-104
-
Price
-
$49.05
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q3 2014
279 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q3 2014.
INCYTE CORP - COMMON STOCK (INCY) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 160M shares
of 194M outstanding shares and own 82.56% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (21M shares), Capital World Investors (17.7M shares), WELLINGTON MANAGEMENT CO LLP (17.3M shares), BAKER BROS. ADVISORS LP (14.8M shares), VANGUARD GROUP INC (8.69M shares), JENNISON ASSOCIATES LLC (7.38M shares), BB Biotech AG (4.3M shares), Artisan Partners Limited Partnership (4.01M shares), BlackRock Institutional Trust Company, N.A. (3.63M shares), and BROWN CAPITAL MANAGEMENT LLC (3.63M shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.